Abcellera Biologics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $657k | 131k | 5.03 |
| 2025-03-31 | $456k | 204k | 2.23 |
| 2024-12-31 | $823k | 281k | 2.93 |
| 2024-09-30 | $925k | 356k | 2.60 |
| 2024-06-30 | $989k | 334k | 2.96 |
| 2024-03-31 | $1.7M | 371k | 4.53 |
| 2023-12-31 | $2.3M | 409k | 5.71 |
| 2023-09-30 | $2.5M | 536k | 4.60 |
| 2023-06-30 | $3.1M | 475k | 6.46 |
| 2023-03-31 | $3.4M | 450k | 7.53 |
| 2022-12-31 | $6.0M | 593k | 10.13 |
| 2022-06-30 | $4.4M | 410k | 10.65 |
| 2022-03-31 | $1.5M | 151k | 9.75 |
| 2021-12-31 | $1.2M | 82k | 14.31 |